| Literature DB >> 32975104 |
Tadej Petreski1,2, Barbara Kit3, Matej Strnad2,4, Damjan Grenc5, Franc Svenšek3.
Abstract
Cholinergic syndrome is a common topic at western medical universities yet rarely observed in clinical practice. The treatment involves muscarinic antagonists, acetylcholinesterase reactivation, seizure control, and supportive measures. Here we report a case of a 52-year old Caucasian male who attempted suicide by ingesting a purple crystal powder that turned out to be a mixture of carbofuran and chlormephos. At clinical examination, the patient presented with salivation, perspiration, diarrhoea, bradypnoea, loss of consciousness, and epileptic seizures. Laboratory tests showed low plasma cholinesterase, and we started obidoxime along with supportive intensive care treatment. He was later transferred to the psychiatry department for further diagnostics and treatment.Entities:
Keywords: carbofuran; chlormephos; critical care; obidoxime
Mesh:
Substances:
Year: 2020 PMID: 32975104 PMCID: PMC7968493 DOI: 10.2478/aiht-2020-71-3413
Source DB: PubMed Journal: Arh Hig Rada Toksikol ISSN: 0004-1254 Impact factor: 2.078